Results 131 to 140 of about 26,934 (150)

NY‐ESO ‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO ‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO ‐1 fowlpox virus

International Journal of Cancer, 2015
Ji-Li Chen, Sacha Gnjatić, Judy Browning   +2 more
exaly  

A further review of ESO type methods for topology optimization

Structural and Multidisciplinary Optimization, 2010
Xiaodong Huang, Yi Min Xie
exaly  

ESO

2011
openaire   +1 more source

A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen

International Journal of Cancer, 2011
Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka   +2 more
exaly  

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1

Cancer Letters, 2006
Özlem Türeci, Frank Krummenauer, Martina Sester   +2 more
exaly  

The ESO method revisited

Structural and Multidisciplinary Optimization, 2014
Kazem Ghabraie
exaly  

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis

Modern Pathology, 2012
Paul F Robbins, Mark Raffeld, Phyu P Aung   +2 more
exaly  

NY-ESO-1 protein expression in primary breast carcinoma and metastases—correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration

International Journal of Cancer, 2007
Jean-Philippe Theurillat, Alfred Zippelius, Zsuzsanna Varga   +2 more
exaly  

Model Free ESO-Based Repetitive Control for Rejecting Periodic and Aperiodic Disturbances

IEEE Transactions on Industrial Electronics, 2017
Zhenwei Cao, Zhihong Man
exaly  

Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432

Vaccine, 2009
Masatoshi Aoki, Shugo Ueda, Hiroaki Ikeda   +2 more
exaly